Duodenal gastrointestinal stromal tumor: Clinical, pathologic, immunohistochemical characteristics, and surgical prognosis

Journal of Surgical Oncology

Volumn 100, Issue 7, 2009, Pages 606-610

  Yang, Wei Li ^a   Yu, Ji Ren ^a   Wu, Yi Jun ^a   Zhu, Kan Kai ^a   Ding, Wei ^a   Gao, Yuan ^a   Shen, Qian Yun ^a   Lv, Ke Zhen ^a   Zhang, Qing ^a   Yang, Xiao Jun ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Duodenum; Gastrointestinal stromal tumors; Immunohistochemistry; Prognosis; Surgery

Indexed keywords

KI 67 ANTIGEN; PROTEIN P16; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; DUODENUM TUMOR; FEMALE; GASTROINTESTINAL STROMAL TUMOR; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MITOSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DEPLETION; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SURVIVAL RATE; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; DUODENAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL STROMAL TUMORS; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 71549164593     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21378     Document Type: Article

References (23)

1. Connolly EM, Gaffney E, Reynolds JV: Gastrointestinal stromal tumours. Br J Surg 2003;90:1178-1186.
2. Fletcher CD, Berman JJ, Corless C, et al.: Diagnosis of gastrointestinal stromal tumors: A consensus approach. Hum Pathol 2002;33:459-465. (Pubitemid 34747864)
3. Miettinen M, Kopczynski J, Makhlouf HR, et al.: Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the duodenum: A clinicopathologic, immunohistochemical, and molecular genetic study of 167 cases. Am J Surg Pathol 2003;27:625-641. (Pubitemid 36514473)
4. Emory TS, Sobin LH, Lukes L, et al.: Prognosis of gastrointestinal smooth-muscle (stromal) tumours: Dependence on anatomic site. Am J Surg Pathol 1999;23:82-87. (Pubitemid 29025244)
5. Wasag B, Debiec-Rychter M, Pauwels P, et al.: Differential expression of KIT/PDGFRA mutant isoforms in epithelioid and mixed variants of gastrointestinal stromal tumors depends predominantly on the tumor site. Mod Pathol 2004;17:889-894. (Pubitemid 38993772)
6. Miettinen M, Sobin LH, Sarlomo-Rikala M: Immunohistochemical spectrum of GISTs at different sites and their differential diagnosis with a reference to CD117 (KIT). Mod Pathol 2000;13:1134-1142. (Pubitemid 30796756)
7. Huang HY, Huang WW, Lin CN, et al.: Immunohistochemical expression of p16INK4A, Ki-67, and Mcm2 proteins in gastrointestinal stromal tumors: Prognostic implications and correlations with risk stratification of NIH consensus criteria. Ann Surg Oncol 2006;13:1633-1644.
8. Wu TJ, Lee LY, Yeh CN, et al.: Surgical treatment and prognostic analysis for gastrointestinal stromal tumors (GISTs) of the small intestine: Before the era of imatinib mesylate. BMC Gastroenterol 2006;6:29.
9. Wong NA, Young R, Malcomson RD, et al.: Prognostic indicators for gastrointestinal stromal tumours: A clinicopathological and immunohistochemical study of 108 resected cases of the stomach. Histopathology 2003;43:118-126. (Pubitemid 36963155)
10. Schneider-Stock R, Boltze C, Lasota J, et al.: Loss of p16 protein defines high-risk patients with gastrointestinal stromal tumors: A tissue microarray study. Clin Cancer Res 2005;11:638-645. (Pubitemid 40116890)
11. Nakamura N, Yamamoto H, Yao T, et al.: Prognostic significance of expressions of cell-cycle regulatory proteins in gastrointestinal stromal tumor and the relevance of the risk grade. Hum Pathol 2005;36:828-837. (Pubitemid 41112040)
12. Blay JY, Bonvalot S, Casali P, et al.: Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO. Ann Oncol 2005;16:566-578.
13. Miettinen M, Sobin LH, Lasota J: Gastrointestinal stromal tumors of the stomach: A clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up. Am J Surg Pathol 2005;29:52-68. (Pubitemid 40023952)
14. Miettinen M, Makhlouf HR, Sobin LH, et al.: Gastrointestinal stromal tumors (GISTs) of the jejunum and ileum: A clinicopathologic, immunohistochemical and molecular genetic study of 906 cases prior to imatinib with long-term follow-up. Am J Surg Pathol 2006;30:477-489. (Pubitemid 43740149)
15. Ghanem N, Altehoefer C, Furtwangler A, et al.: Computed tomography in gastrointestinal stromal tumors. Eur Radiol 2003;13:1669-1678. (Pubitemid 36869362)
16. Aydin A, Tekin F, Güns,ar F, et al.: Value of endoscopic ultrasonography for upper gastrointestinal stromal tumors: A single center experience. Turk J Gastroenterol 2004;15:233-237. (Pubitemid 40188883)
17. Sandrasegaran K, Rajesh A, Rushing DA, et al.: Gastrointestinal stromal tumors: CTand MRI findings. Eur Radiol 2005;15:1407-1414. (Pubitemid 40983524)
18. Nagakawa T, Ueno K, Ohta T, et al.: Evaluation of long-term survivors after pancreatoduodenectomy for pancreatoduodenal carcinoma. Hepatogastroenterology 1995;42:117-122.
19. DeMatteo RP, Lewis JJ, Leung D, et al.: Two hundred gastrointestinal stromal tumors: Recurrence patterns and prognostic factors for survival. Ann Surg 2000;231:51-58. (Pubitemid 30043939)
20. Sun YH, Wang XF, Hou YY, et al.: Clinical characteristics and surgical treatment of 18 cases of duodenal gastrointestinal stromal tumors. Zhonghua Wei Chang Wai Ke Za Zhi 2007;10:26-28.
21. Rossi S, Ou W, Tang D, et al.: Gastrointestinal stromal tumours overexpress fatty acid synthase. J Pathol 2006;209:369-375. (Pubitemid 43997746)
22. Feakins RM: The expression of p53 and bcl-2 in gastrointestinal stromal tumours is associated with anatomical site, and p53 expression is associated with grade and clinical outcome. Histopathology 2005;46:270-279.
23. Lane DP: p53, guardian of the genome. Nature 1992;358:15-16.